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1. MULTIPLE ORGAN DYSFUNCTION INDUCED BY ALPROSTADILUM IN 
A PATIENT DIAGNOSED WITH SCLERODERMA (SYSTEMIC SCLEROSIS)
Alexandru Emil Baetu, Andreea-Iuliana Miron, Oana Mihaela Punga
Scientific advisor: Monica Copotoiu, MD, PhD, University of Medicine and Pharmacy Targu Mures,
Romania
Introduction: Painful, slow-healing ulcers of the fingers are most common in patients with 
progressive systemic sclerosis. Prostaglandine E1(PGE1) is a vasodilatator that has been found to reduce 
the pain of the severe periphereal arterisclerotic vascular disease and to promote healing of the 
accompanying ulcers.
Clinical case: We present the case of a 46-years old, female, allergic to Hymenoptera venom, 
and witch in 2010 received swine flu vaccine. In october 2010, she reach on the departament of 
Rheumatology, Targu Mures accusing pain and swelling in the extremities, skin changes at the same 
level accompanied by vasomotor disturbances at cold. Having in mind this clinical appearance of skin, 
typical for scleroderma, Associated with the mesenchymal nonspecific inflammatory syndrome proven 
by laboratory test, with increased antibody titer (antinuclear antibodies-ANA: 45.2 UI/ml and 
topoisomerase-I antibodies-anti Scl 70: 39.5 UI/ml) and after radiographic appearance of early
resorption of the distal phalanx, IV finger, right hand is given a diagnosis of progressive systemic 
scleroderma and we have initiated a background treatment with methotrexate. But after two months the 
disease progresses rapidly with necrotizing vasculitis and pulmonary injury. So we initiated a treatment 
with cyclophosphamide 600 mg intravenously with favorable evolution until October 2011 when it
stopped due to a suspected hemorrhagic cystitis, and when peripheral ischemia occur we decide to 
introduce back azathioprine in the treatment plan but with modest results resuming the treatment with 
Cyclophosphamide in May 2012, which was Associated with Alprostadilum and in February 2013
reenter Methotrexate. In january 2014,after the treatment with Alprostadilum, the patient suddenly 
accuse chills, low grade fever, muscular pain, without auscultatory lung changes, arrhythmic heart 
sounds, with ischemic changes on electrocardiogram, rising the suspicion of an acute coronary 
syndrome, but which was rejected after cardiological examination. Subsequently, after two days, the 
patient presents coffee grounds vomiting for which was made an upper gastrointestinal endoscopy in 
emergency, which shows no active bleeding source. Concidering progressive hemodynamic alterations, 
the patient is transferred in Gastroenterology Clinic where is established the diagnosis of acute gastric 
ulcer with upper gastrointestinal bleeding. After 2 weeks, the patient presents in the emergency room in 
bad general condition with necrotic changes in the fingers and she was hospitalized to the intensive care 
unit with inflammatory syndrome, marked anemia, hepatic and renal failure, pleural effusion fluid with 
cytopathology diagnosis of atypical cells and suspected neoplastic process having a rapidly evolution to 
death.
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In conclusion even if we considered all aspects and risk factors related to the patient’s disease, 
when we prescribe Alprostadilum we should expect to face a tragic outcome.
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2. GESTATIONAL GIGANTOM ASTIA SURGICAL TREAT MENT 
PROCEDURE
Dr. Ben-Tsrooya 
Scientific advisor: Prof. Avshalom , Head of Department, Plastic Surgery, MEIR Hospital, Israel
Introduction: Physiological enlargement of the breasts occurs at puberty and during pregnancy. 
It is known as gestational gigantomastia when enlargement in pregnancy becomes excessive, 
uncomfortable and embarrassing. Gestational gigantomastia may have far reaching effects for the mother 
and fetus. This rare condition is Associated with considerable morbidity but may be Associated with 
good fetal outcome. Our case was very special in the surgical approach. Gestational gigantomastia is a 
very rare condition and only about 100 cases have been reported in the literature. The breasts are of vital 
importance to the newborn child, particularly in developing countries where breast feeding is common. 
Breast feeding confers numerous advantages on the infant including reduced mortality rate and improved 
neurological development. Physiological enlargement of the breasts occurs at puberty and during 
pregnancy, when it starts very early and is sustained until delivery. The factors controlling breast growth 
are complex and not completely understood, although estrogens, progesterone, prolactin, growth 
hormone and adrenal steroids are all known to play a role. Sometimes this process goes wrong resulting 
in an excessively large and painful breast called gestational gigantomastia (gravida gigantomastia, 
mammary hyperplasia of pregnancy) or virginal hyperplasia when it occurs at puberty. This rare but 
important condition of the breast not only interferes with breast feeding but may cause severe maternal 
morbidity and even mortality.
Clinical case: Gestational gigantomastia is a very rare condition and only about 100 cases have 
been reported in the literature. The breasts are of vital importance to the newborn child, particularly in 
developing countries where breast feeding is common. Breast feeding confers numerous advantages on 
the infant including reduced mortality rate and improved neurological development. Physiological 
enlargement of the breasts occurs at puberty and during pregnancy, when it starts very early and is 
sustained until delivery. The factors controlling breast growth are complex and not completely 
understood, although estrogens, progesterone, prolactin, growth hormone and adrenal steroids are all
known to play a role. Sometimes this process goes wrong resulting in an excessively large and painful 
breast called gestational gigantomastia (gravida gigantomastia, mammary hyperplasia of pregnancy) or 
virginal hyperplasia when it occurs at puberty. This rare but important condition of the breast not only 
interferes with breast feeding but may cause severe maternal morbidity and even mortality.
Discussion: Gestational gigantomastia was first described in 1684 by Palmuth, and is very rare. 
An incidence of 1 in 28.000 to 1 in 100.000 pregnancies has been quoted. It is a severely debilitating 
condition in which massive enlargement of the breasts may be accompanied by thinning of the skin, 
tissue necrosis, infection and hemorrhages. Movement and respiratory difficulty and emotional, social 
13
